Meta-Flux

Seed
meta-flux.com Biotech & Healthcare
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Oct 13, 2025
Investors Undisclosed
Decision Makers 2 Verified

About Meta-Flux

Meta-Flux is building the intelligence layer to simulate disease — high-fidelity in-silico models that let researchers run experiments across oncology, neurodegeneration, and immuno-oncology.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website meta-flux.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Seed announced

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Meta-Flux.

Funding History

1 Round
Seed · Oct 13, 2025

Founders & Leadership

2

Brendan Martin

Founder & Chief Technology Officer

Work email & phone locked Unlock →

Lee Sherlock

Founder & Chief Executive Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts